Topic

Treatment Underuse

Fillmore and his collaborators have examined the systemic drivers of treatment underuse, specifically regarding the administration of antiviral therapies for high-risk patients with COVID-19. His research indicates that provider failure to offer recommended medications is a primary barrier to care, contributing to preventable risks of severe disease and mortality. These findings suggest that standardized follow-up protocols and enhanced clinician education are necessary to close gaps in therapeutic delivery.

U.S. Veterans and VA Data 1 COVID-19 1 Severe COVID-19 1 Antiviral Therapy 1 Hematologic Malignancies 1 Solid Organ Transplantation 1 Vaccination 1 Patient Outcomes 1

Publications (1)

2024

Underuse of Antiviral Drugs to Prevent Progression to Severe COVID-19 - Veterans Health Administration, March-September 2022.

Paul A. Monach, Sonia T. Anand, Nathanael R. Fillmore, Jennifer La, Westyn Branch-Elliman

MMWR: Morbidity and Mortality Weekly Report73(3), 57-61

U.S. Veterans and VA Data COVID-19 Severe COVID-19 Antiviral Therapy Hematologic Malignancies